Tuesday, November 29, 2016

New Mesothelioma Clinical Trials in Texas and Pennsylvania

0
New Mesothelioma Clinical Trials in Texas and Pennsylvania -

There are currently two clinical trials seeking mesothelioma patients. The first is looking for patients with advanced stages of pleural mesothelioma in Pennsylvania and Texas. Merck & Co., Inc., a global pharmaceutical company, leads the study of the effects of vorinostat, which is a type of histone deacetylase inhibitor. Participation is generally a period of 24 weeks. The second is led by Anderson Cancer Center in Houston M.D. and the Novartis pharmaceutical company to test the effects of cisplatin, pemetrexed and Imatinib mesylate. This test is also for patients diagnosed with advanced mesothelioma.

More information about the clinical trial Pennsylvania mesothelioma.
More information about the clinical trial mesothelioma MD Anderson.

Participation in a clinical trial mesothelioma is a personal choice. Only you can make the decision to participate in clinical research mesothelioma. With a cancer like mesothelioma, clinical trials are one of the best opportunities researchers must determine the benefits and risks of new mesothelioma treatment and as treatment options are currently limited to patients with mesothelioma, clinical trials may hold the answer to help slow the aggressive nature of the disease.

There are benefits and risks associated with participation in a clinical trial. When you participate in clinical trials, you will generally receive health care of a leading physician in the field and your health during the trial will be monitored very closely. If the approach to the study is useful, you'll be among the first to benefit, and there is the satisfaction of knowing you made a valuable contribution to the research of mesothelioma. However, when participating in clinical trials, you are also subject to unknown risks and effects of various secondary treatments. There is also the risk that a new drug or procedure may not be as effective as the current treatment options and the new approach may not work for you at all.

You should always consult your oncologist to determine whether your participation in a clinical trial may be beneficial for your condition. It is also important to know that the government has a system in place to protect only the human research projects funded by the government, which includes both the protocol and informed consent. More importantly, you should never feel compelled to participate and you can change your mind about the study once you have been fully informed about the procedures, tests and time required. Once you have been diagnosed with mesothelioma, your time is precious, and you should use this time to what you want.

Author Image

About Waektra
Soratemplates is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design